Bortezomib Waverley Pharma Europe 1 mg inj. sol. (pwdr.) i.v. vial Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib waverley pharma europe 1 mg inj. sol. (pwdr.) i.v. vial

waverley pharma europe ltd. - bortezomib mannitol boronic ester - eq. bortezomib 1 mg - powder for solution for injection - 1 mg - bortezomib mannitol boronic ester - bortezomib

Bortezomib Waverley Pharma Europe 3,5 mg inj. sol. (pwdr.) s.c./i.v. vial Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bortezomib waverley pharma europe 3,5 mg inj. sol. (pwdr.) s.c./i.v. vial

waverley pharma europe ltd. - bortezomib mannitol boronic ester - eq. bortezomib 3,5 mg - powder for solution for injection - 3,5 mg - bortezomib mannitol boronic ester - bortezomib

VORTEMYEL 3.5mg Powder for Solution for Injection Málta - angol - Medicines Authority

vortemyel 3.5mg powder for solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - bortezomib - solution for injection - bortezomib 3.5 mg - antineoplastic agents

Bortezomib Biotech Pharma 3.5 mg powder for solution for injection Írország - angol - HPRA (Health Products Regulatory Authority)

bortezomib biotech pharma 3.5 mg powder for solution for injection

biotech pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - bortezomib

Bortezomib Pharmidea 3.5 mg powder for solution for injection Málta - angol - Medicines Authority

bortezomib pharmidea 3.5 mg powder for solution for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - bortezomib - powder for solution for injection - bortezomib 3.5 mg - antineoplastic agents

Bortezomib 2.5 mg powder for solution for injection Írország - angol - HPRA (Health Products Regulatory Authority)

bortezomib 2.5 mg powder for solution for injection

european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 2.5 milligram(s) - bortezomib